S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Aktualne aktualizacje dla Anthem Inc. Corporate [ANTX]

Giełda: NYSE Sektor: Healthcare Branża: Biotechnology
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 9.50%

BUY
100.00%
return 0.27%
SELL
0.00%
return 0.00%
Ostatnio aktualizowano3 geg. 2024 @ 23:00

0.79% $ 2.56

SPRZEDAż 124569 min ago

@ $20.32

Wydano: 8 vas. 2024 @ 16:30


Zwrot: -87.40%


Poprzedni sygnał: vas. 6 - 19:43


Poprzedni sygnał: Kupno


Zwrot: 0.27 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases...

Stats
Dzisiejszy wolumen 167 963
Średni wolumen 480 919
Kapitalizacja rynkowa 76.21M
EPS $-0.650 ( 2023-11-09 )
Następna data zysków ( $-0.610 ) 2024-05-09
Last Dividend $0.656 ( 2018-01-11 )
Next Dividend $0 ( N/A )
P/E -0.930
ATR14 $0.0120 (0.47%)
Insider Trading
Date Person Action Amount type
2024-03-15 Eckburg Paul Buy 30 000 Common Stock
2024-03-15 Day Lucy Buy 55 000 Stock Option (right to buy)
2024-03-15 Day Lucy Buy 27 500 Common Stock
2024-03-15 Eizen Joshua M Buy 60 000 Stock Option (right to buy)
2024-03-15 Eizen Joshua M Buy 30 000 Common Stock
INSIDER POWER
65.40
Last 100 transactions
Buy: 3 449 514 | Sell: 642 134

Wolumen Korelacja

Długi: -0.18 (neutral)
Krótki: 0.84 (strong)
Signal:(51.581) Same movement expected

Anthem Inc. Corporate Korelacja

10 Najbardziej pozytywne korelacje
SFL0.949
MIC0.937
X0.923
APO-PA0.921
FLSP0.92
UBS0.912
CEIX0.907
PSN0.903
CXW0.901
HRB0.898
10 Najbardziej negatywne korelacje
HE-0.92
ENIA-0.915
AGTI-0.909
RMD-0.906
SFUN-0.903
FNA-0.899
NWE-0.899
K-0.898
HIPO-0.89
NUV-0.888

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Anthem Inc. Corporate Korelacja - Waluta/Towar

The country flag -0.41
( neutral )
The country flag -0.45
( neutral )
The country flag 0.00
( neutral )
The country flag -0.41
( neutral )
The country flag 0.54
( weak )
The country flag 0.58
( weak )

Anthem Inc. Corporate Finanse

Annual 2023
Przychody: $0
Zysk brutto: $0 (0.00 %)
EPS: $-2.74
FY 2023
Przychody: $0
Zysk brutto: $0 (0.00 %)
EPS: $-2.74
FY 2022
Przychody: $0
Zysk brutto: $-77 000.00 (0.00 %)
EPS: $-2.14
FY 2021
Przychody: $0.00
Zysk brutto: $0.00 (0.00 %)
EPS: $-1.534

Financial Reports:

No articles found.

Anthem Inc. Corporate Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Anthem Inc. Corporate Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $0.576 2015-07-13
Last Dividend $0.656 2018-01-11
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 11 --
Total Paid Out $7.14 --
Avg. Dividend % Per Year 0.00% --
Score 1.61 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-06-24)
$0 Estimate 0.00 %
Dividend Stability
0.07 Very Bad
Dividend Score
1.61
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0.656 1.15%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
ORC Dividend Royal 2023-11-29 Monthly 12 9.23% 8.50
SRV Dividend Royal 2023-12-04 Monthly 18 7.53% 8.50
NCZ Dividend Royal 2024-02-09 Monthly 22 7.79% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-0.4611.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.5901.500-7.67-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM7.870.80010.008.00[1 - 3]
quickRatioTTM7.740.80010.008.00[0.8 - 2.5]
cashRatioTTM1.1141.5004.927.38[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM97.261.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-1.7922.00-0.597-1.195[0 - 30]
freeCashFlowPerShareTTM-1.7922.00-0.896-1.792[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score-0.272

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.1891.000-0.2210[1 - 100]
returnOnEquityTTM-0.5902.50-4.93-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.7922.00-0.597-1.792[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.7922.00-0.597-1.195[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.02071.500-3.200[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.990

Anthem Inc. Corporate

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej